Nkarta (NKTX) Earnings Date & Reports

A.I. Advisor

published Earnings

NKTX is expected to report earnings to rise 7.35% to -36 cents per share on November 06

Q3'24

Est.

$-0.37

Q2'24

Beat

by $0.13

Q1'24

Missed

by $0.03

Q4'23

Beat

by $0.01

Q3'23

Beat

by $0.15

The last earnings report on August 13 showed earnings per share of -34 cents, beating the estimate of -46 cents. With 395.31K shares outstanding, the current market capitalization sits at 318.93M.

View a ticker or compare two or three

Compare

NKTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NKTX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NKTX (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1150 Veterans Boulevard

Phone

+1 905 407-1049

Employees

150

Web

https://www.nkartatx.com